ENVESTNET ASSET MANAGEMENT INC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1407543 Berwyn, PA

Position in CRNX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$5,471,402

-$532 QoQ

Shares Held

146,216

-2.9% QoQ

Ownership

0.138%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#63

of 266 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. CRNX ranks #31 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	487,627	$242,218,959
2	REGN	Regeneron Pharmaceuticals, Inc.	109,838	$68,488,386
3	EXEL	Exelixis, Inc.	949,669	$51,671,490
4	ARGX	Argenx SE	55,346	$51,348,358
5	ALNY	Alnylam Pharmaceuticals, Inc.	136,395	$41,058,986
6	INSM	INSMED Inc	336,997	$35,930,620
7	RPRX	Royalty Pharma plc	513,096	$28,769,292
8	ROIV	Roivant Sciences Ltd.	713,946	$25,266,548

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,471,402	146,216	-2.9%	Shares	Sole	2026-08-03
2026-03-31	$5,471,934	150,659	+15.6%	Shares	Sole	2026-05-04
2025-12-31	$6,068,397	130,363	+147.5%	Shares	Sole	2026-02-10
2025-09-30	$2,193,497	52,665	-2.9%	Shares	Sole	2025-11-05
2025-06-30	$1,560,460	54,258	-4.3%	Shares	Sole	2025-08-01
2025-03-31	$1,901,416	56,691	-10.1%	Shares	Sole	2025-04-29
2024-12-31	$3,225,127	63,077	+16.1%	Shares	Sole	2025-02-13
2024-09-30	$2,776,058	54,326	+4.9%	Shares	Sole	2024-11-07
2024-06-30	$2,319,718	51,791	+23.5%	Shares	Sole	2024-08-08
2024-03-31	$1,962,836	41,932	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.